Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Thalidomide in Preventing Multi-cycle, Cisplatin-containing CINV: a Pragmatic Randomized Open-label Clinical Trial

NCT03601871 is registered in ClinicalTrials.gov with Yunpeng Liu as lead sponsor.

NCT NCT03601871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03601871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Thalidomide in Preventing Multi-cycle, Cisplatin-containing CINV: a Pragmatic Randomized Open-label Clinical Trial
Lead sponsor
Yunpeng Liu
Phase
Not applicable
Overall status
Unknown status
Start date
July 12, 2018
Completion date
December 30, 2020
Enrollment
880 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced nausea and vomiting